Gelecek Varlık Yönetimi A.Ş. (“Gelecek Varlık”), a leading asset management company operating under Fiba Group, and Anatolia Tanı ve Biyoteknoloji Ürünleri Sanayi ve Ticaret A.Ş. (“Anatolia”), a leading company in molecular diagnosis industry, successfully completed their initial public offerings (“IPO”) and were listed on Borsa Istanbul on the same day, 21 October 2021.
The IPO of Anatolia reached a size of TRY 516,9 million and the IPO of Gelecek Varlık reached a size of TRY 360,4 million and the both IPOs were oversubscribed and attracted a very strong demand by investors. Anatolia with the ticker of “ANGEN” and Gelecek Varlık, with the ticker of “GLCVY”, are trading on Borsa İstanbul as of 21 October 2021. For the first time in Borsa İstanbul’s history, a joint bell-ringing ceremony was held for two companies.
Paksoy is pleased to announce that the deal teams led by partners Omer Collak and Sera Somay together with counsel Ökkeş Şahan, senior associates Soner Dağlı and Merve Kurdak, and associate Bülent Öztürk acted as transaction counsel in these IPOs.
Share
Related persons
You can contact us for detailed information.





Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
29 September 2025
Paksoy advises Merrill Lynch International on Vakıfbank share sale
Paksoy has advised the sole global coordinator and bookrunner, Merrill Lynch International, on the sale of 1.53% of the shares owned by…
25 September 2025
At Paksoy, we have implemented Legora, an industry-leading Generative AI platform designed for legal professionals, across the firm in all our practices
At Paksoy, we have implemented Legora, an industry-leading Generative AI platform designed for legal professionals, across the firm in all…
23 September 2025
Paksoy has been named “Türkiye Firm of the Year” at the Benchmark Litigation Europe Awards 2025
Paksoy has been named “Türkiye Firm of the Year” at the Benchmark Litigation Europe Awards 2025.
17 September 2025
Paksoy advises Ege Kimya on its recent acquisitions of Venator Materials’ Driers Book of Business and 100% of the shares in Metal Oksit
Ege Kimya is a leading Turkish chemicals company with operations in intermediate chemicals serving both domestic and international markets.…
9 September 2025
Paksoy advises Parsan, a Güriş Holding company listed on Borsa Istanbul, on the merger with Omtaş
Parsan, a Güriş Holding group company listed on Borsa Istanbul and active in integrated steel forging and machining business, has now…
4 September 2025
Paksoy advises Solventum on sale of purification and filtration business to Thermo Fisher
Solventum, an American healthcare company spun off from 3M in 2024, has completed the sale of its purification and filtration business to…